OTC & Nutraceuticals China

China Fertility Supplements Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

China Fertility Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, User, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $205.5 Mn Placeholder estimate
Estimate 2025 $225.1 Mn 8.8% of the global market
Projected 2034 $509.4 Mn 126.3% Adds $284.3 Mn over 9 forecast years
CAGR 2025–2034 9.5% Faster than 74% of 82 OTC & Nutraceuticals markets here
Key players 5
  • China is 8.77% of the global market.
  • In APAC, the largest is China (this report) at $225.1 Mn.
  • Fastest growing: India at 10.9% a year.
  • China ranks 1st of 10 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$284.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Fertility Supplements Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $205.5 Mn — —
2025 (base) $225.1 Mn +$19.5 Mn —
2026 (forecast) $246.4 Mn +$21.4 Mn +9.5%
2027 (forecast) $269.8 Mn +$23.4 Mn +19.9%
2028 (forecast) $295.5 Mn +$25.6 Mn +31.3%
2029 (forecast) $323.6 Mn +$28.1 Mn +43.8%
2030 (forecast) $354.3 Mn +$30.7 Mn +57.4%
2031 (forecast) $388.0 Mn +$33.7 Mn +72.4%
2032 (forecast) $424.8 Mn +$36.9 Mn +88.8%
2033 (forecast) $465.2 Mn +$40.4 Mn +106.7%
2034 (forecast) $509.4 Mn +$44.2 Mn +126.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.57 Bn
  2. North America $1.17 Bn
  3. US $1.02 Bn
  4. APAC $589.8 Mn
  5. Europe $437.7 Mn
  6. China (this report) $225.1 Mn
  7. Canada $185.6 Mn
  8. Japan $156.4 Mn
  9. Latin America $122.1 Mn
  10. Germany $97.9 Mn
  11. Middle East $102.1 Mn
  12. France $72.6 Mn
  13. UK $70.4 Mn
  14. Brazil $71.5 Mn
  15. Italy $56.7 Mn
  16. Ecuador $55.6 Mn
  17. Spain $53.3 Mn
  18. Saudi Arabia $49.4 Mn
  19. India $49.6 Mn
  20. Mexico $34.3 Mn
  21. Africa $34.3 Mn
  22. New Zealand $29.6 Mn
  23. Russia $28.5 Mn
  24. Australia $28.5 Mn
  25. South Africa $18.8 Mn
  26. UAE $12.9 Mn
  27. Egypt $8.4 Mn
  28. Philippines $6.6 Mn
  29. Malaysia $3.9 Mn
  30. Hong Kong $3.8 Mn
  31. Thailand $3.0 Mn
  32. Singapore $2.8 Mn
  33. Kenya $1.7 Mn

Report snapshot

China Fertility Supplements Market Analysis at a glance
Market size, 2025$225.1 Mn placeholder estimate
Forecast, 2034$509.4 Mn placeholder estimate
Growth (CAGR), 2025–20349.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsIngredient, user and distribution channel (see all)
Key playersBayer AG, Fairhaven Health, Theralogix, Nature Made, Proov (see all)
Regulator in ChinaNMPA and SAMRSource: National Medical Products Administration. Checked 14 Nov 2026.Source: State Administration for Market Regulation. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The China Fertility Supplements Market Analysis Executive Summary

Fertility supplements contain vitamins and nutrients such as folate, CoQ10 and inositol, marketed to support fertility in women and men.

Key segments of the fertility Supplements market include ingredient (Folic Acid, CoQ10 and Myo-Inositol) and user (Women and Men).

Bar chart: China Fertility Supplements market size, 2024–2034, placeholder estimates. $205.5 Mn in 2024, $225.1 Mn in 2025 and $509.4 Mn in 2034, 9.5% CAGR.
China Fertility Supplements market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

China Fertility Supplements Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the fertility Supplements market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the fertility Supplements market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the fertility Supplements market.

Competitive Landscape for Fertility Supplements Market in China

The fertility Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Fertility Supplements Market in China

Fertility Supplements in China: rules

Drugs need approval from the National Medical Products Administration (NMPA) before sale.⁠[1] Health foods, sold with a blue-hat logo, must be registered or filed with the State Administration for Market Regulation (SAMR).⁠[2]

[1] National Medical Products Administration. Checked 14 Nov 2026.

[2] State Administration for Market Regulation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern fertility Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in China.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Fertility Supplements right now, from free public sources.

Latest research 1,963 papers since 2021 (worldwide)

  1. The effects of saffron and crocin in enhancing male fertility: insights from clinical and preclinical studies. Natural product research, 2026
  2. Monogenic defects in Holstein-Friesian cattle: carrier frequency, temporal trends and breeding indices. Animal : an international journal of animal bioscience, 2026
  3. [Clinical value of viable spermatozoa DFI in infertile patients with high fragmentation rate of sperm DNA]. Zhonghua nan ke xue = National journal of andrology, 2026
  4. The improvement effect of androgen priming on fertility in patients with diminished ovarian reserve and its impact on in vitro fertilization outcomes: a systematic review and meta-analysis. Frontiers in endocrinology, 2026
  5. Riociguat supplementation modulates post-thaw ram sperm quality in a dose-dependent manner through effects on motility, membrane integrity and oxidative balance. Veterinary research forum : an international quarterly journal, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Fertility Supplements in context

China compared

  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 6th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Fertility Supplements market in China?
Placeholder estimate: about $225.1 Mn in 2025, rising to about $509.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Fertility Supplements market in China growing?
Placeholder estimate: about 9.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Fertility Supplements market report cover?
The report splits the market by ingredient (Folic Acid, CoQ10, Myo-Inositol, Zinc and more), user (Women, Men) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Fertility Supplements market?
Key players include Bayer AG, Fairhaven Health, Theralogix, Nature Made and Proov.
What is driving the Fertility Supplements market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the fertility Supplements market. New products designed around women's biology and digital care are improving access.
Who regulates Fertility Supplements in China?
Drugs need approval from the National Medical Products Administration (NMPA) before sale. Health foods, sold with a blue-hat logo, must be registered or filed with the State Administration for Market Regulation (SAMR). Source: National Medical Products Administration. Checked 14 Nov 2026. Source: State Administration for Market Regulation. Checked 14 Nov 2026.
How much research is published on Fertility Supplements?
PubMed lists 1,963 papers on Fertility Supplements added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Fertility Supplements in China? Our analysts can size it for your plan. Talk to us See the public data Teenage births for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Herbal Supplements: Quality, Safety and Trust170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Back to Catalogue
Keep exploring

Related OTC & Nutraceuticals reports in China

See all
Same topic, other categories

Related on fertility and nutrition

See the topic